(Q35104635)

6 August 2017

1 reference

title

Potentially significant drug interactions of class III antiarrhythmic drugs (English)

1 reference

6 August 2017

Potentially Significant Drug Interactions of Class III Antiarrhythmic Drugs (English)

1 reference

Crossref

https://api.crossref.org/works/10.2165/00002018-200326060-00004

23 December 2023

1 reference

https://api.crossref.org/works/10.2165/00002018-200326060-00004

23 December 2023

author name string

Weeranuj Yamreudeewong

1

1 reference

6 August 2017

Michael DeBisschop

2

1 reference

6 August 2017

Linda G. Martin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12688833

23 December 2023

Dennis L. Lower

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12688833

23 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12688833

23 December 2023

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

26

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

421-438

1 reference

A review of class III antiarrhythmic agents for atrial fibrillation: maintenance of normal sinus rhythm

6 August 2017

cites work

1 reference

12 December 2020

Prazosin first dose phenomenon during combined treatment with a beta-adrenoceptor blocker in hypertensive patients

1 reference

12 December 2020

Pharmacokinetic and electrophysiologic interactions of amiodarone and procainamide

1 reference

12 December 2020

Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833

1 reference

12 December 2020

Drug interactions with amiodarone

1 reference

12 December 2020

Combination of clonidine and sotalol in hypertension

1 reference

12 December 2020

Current and new drugs for the treatment of arrhythmias.

1 reference

12 December 2020

Differential Effects of Amiodarone and Desethylamiodarone on Calcium Antagonist Receptors

1 reference

12 December 2020

Amiodarone in the management of cardiac arrhythmias: current concepts

1 reference

12 December 2020

Molecular and physical mechanisms of first-pass extraction

1 reference

12 December 2020

Effects of amiodarone on oral and intravenous digoxin kinetics in healthy subjects

1 reference

12 December 2020

Serious interactions of sotalol with amiodarone and flecainide

1 reference

12 December 2020

Mechanism of warfarin potentiation by amiodarone: dose--and concentration--dependent inhibition of warfarin elimination.

1 reference

12 December 2020

Antiretroviral therapy increases serum concentrations of amiodarone

1 reference

12 December 2020

Possible interaction between amiodarone and phenytoin

1 reference

12 December 2020

Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children <1 year of age.

1 reference

12 December 2020

Hypokalaemia induced by a combination of a beta-blocker and a thiazide

1 reference

12 December 2020

Efficacy of bretylium tosylate for ventricular tachycardia

1 reference

12 December 2020

Evolution, mechanisms, and classification of antiarrhythmic drugs: focus on class III actions

1 reference

12 December 2020

Sotalol, hypokalaemia, syncope, and torsade de pointes

1 reference

12 December 2020

Amiodarone and beta-adrenergic blockers: an interaction with metoprolol but not with atenolol

1 reference

12 December 2020

Interaction between warfarin sodium and amiodarone

1 reference

12 December 2020

Amiodarone interaction with lidocaine.

1 reference

12 December 2020

Calcium antagonists. Drug interactions of clinical significance

1 reference

12 December 2020

Dangers of amiodarone and anticoagulant treatment

1 reference

12 December 2020

Interaction between sotalol and an antacid preparation

1 reference

12 December 2020

P-glycoprotein and multidrug resistance

1 reference

12 December 2020

Renal handling of captopril: effect of probenecid

1 reference

12 December 2020

Effect of probenecid on the disposition of captopril and captopril dimer in the rat.

1 reference

12 December 2020

Sinoatrial arrest due to lidocaine injection in sick sinus syndrome during amiodarone administration

1 reference

12 December 2020

Prospective study of the potentiation of acenocoumarol by amiodarone

1 reference

12 December 2020

Amiodarone-cyclosporine interaction in a heart transplant patient

1 reference

12 December 2020

Pharmacokinetic interaction between intravenous phenytoin and amiodarone in healthy volunteers

1 reference

12 December 2020

Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation. The Sotalol Study Group

1 reference

12 December 2020

[Acceleration of amiodarone elimination by cholestyramine]

1 reference

12 December 2020

Use of cholestyramine in the treatment of digoxin intoxication

1 reference

12 December 2020

A benefit-risk assessment of class III antiarrhythmic agents

1 reference

12 December 2020

Influence of amiodarone on oral digoxin bioavailability in healthy volunteers

1 reference

12 December 2020

The theophylline-erythromycin interaction

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic implications of P-glycoprotein modulation

1 reference

12 December 2020

Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators

1 reference

12 December 2020

Problems of anticoagulation with warfarin in hyperthyroidism

1 reference

12 December 2020

The dilemma of the prolonged QT interval in early drug studies.

1 reference

12 December 2020

Asystole produced by the combination of amiodarone and digoxin

1 reference

12 December 2020

Effects of grapefruit juice and orange juice on the intestinal efflux of P-glycoprotein substrates.

1 reference

12 December 2020

Effect of phenytoin on the clinical pharmacokinetics of amiodarone.

1 reference

12 December 2020

Effect of cimetidine and ranitidine on pharmacokinetics and pharmacodynamics of a single dose of dofetilide

1 reference

12 December 2020

Variable disposition kinetics and electrocardiographic effects of flecainide during repeated dosing in humans: contribution of genetic factors, dose-dependent clearance, and interaction with amiodarone

1 reference

12 December 2020

Antiarrhythmic agents: current status and perspectives

1 reference

12 December 2020

Sinus arrest and hypotension with combined amiodarone-diltiazem therapy

1 reference

12 December 2020

Amiodarone pharmacokinetics

1 reference

12 December 2020

The incidence, magnitude, and time course of the amiodarone-warfarin interaction

1 reference

12 December 2020

Effects of oral vitamin K on S- and R-warfarin pharmacokinetics and pharmacodynamics: enhanced safety of warfarin as a CYP2C9 probe

1 reference

12 December 2020

Immediate cardiovascular responses to oral prazosin--effects of concurrent beta-blockers

1 reference

12 December 2020

Rapid clonidine withdrawal with blood pressure overshoot exaggerated by beta-blockade

1 reference

12 December 2020

Amiodarone-digoxin interaction: clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications

1 reference

12 December 2020

A Classification of Antiarrhythmic Actions Reassessed After a Decade of New Drugs

1 reference

12 December 2020

Update: clinically significant cytochrome P-450 drug interactions

1 reference

12 December 2020

beta-blockers. Drug interactions of clinical significance

1 reference

12 December 2020

Amiodarone: what have we learned from clinical trials?

1 reference

12 December 2020

Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy

1 reference

12 December 2020

Antiarrhythmic agent amiodarone possesses calcium channel blocker properties

1 reference

12 December 2020

Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias

1 reference

12 December 2020

Drug Metabolism and Disposition

33

27

161

Hall

1999

1 reference

Crossref

https://api.crossref.org/works/10.2165/00002018-200326060-00004

The Quarterly Journal of Medicine

23 December 2023

46

58

43

Kellett

1986

1 reference

Crossref

https://api.crossref.org/works/10.2165/00002018-200326060-00004

23 December 2023

Identifiers

1 reference

Dimensions Publication ID

6 August 2017

1052212706

0 references

1 reference